View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obe...

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discussion moderated by Edward Tentoff, Managing Director, Senior Biotechnology Analyst. Investors can register for the symposium by contacting their Piper Sandler representative. About OPKO Health OPKO is a multinational biopharmaceutical and diagnostics ...

 PRESS RELEASE

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Gluc...

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that new pharmacologic and pharmacokinetic in vivo data for investigational oral OPK-88006 tablet treatment has been selected for presentation at the ENDO 2025 annual meeting of the Endocrine Society, taking place July 12-15, 2025 in San Francisc...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 23, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

THOR Industries Announces Re-Authorization of $400 Million Share Buyba...

THOR Industries Announces Re-Authorization of $400 Million Share Buyback ELKHART, Ind., June 23, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors has retired the Company’s existing share repurchase authorization which was set to expire on July 31, 2025 and re-authorized the Company to repurchase up to $400 million of its Common Stock.  The Company may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means. The timing and amount of any transactions will ...

 PRESS RELEASE

THOR Industries Announces Regular Quarterly Dividend

THOR Industries Announces Regular Quarterly Dividend ELKHART, Ind., June 18, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors approved, at its June 18, 2025, meeting, the payment of a regular quarterly cash dividend of $0.50 per share. The regular cash dividend is payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025. About THOR Industries, Inc. THOR is the sole owner of operating companies which, combined, represent the world's largest manufacturer of recreational vehicles. For more informati...

 PRESS RELEASE

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Adv...

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer ModeX’s promising immunology pipeline includes first-in class drugs with two assets in ongoing clinical trials and multiple pre-IND assets to enter clinical trials WESTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), to...

 PRESS RELEASE

THOR Industries Announces Third Quarter Fiscal 2025 Results

THOR Industries Announces Third Quarter Fiscal 2025 Results CONTINUED EXECUTION OF KEY STRATEGIES LEADS TO STRONG QUARTER AS INITIATIVES BEGIN TO SHOW EFFECTS Fiscal 2025 Third Quarter Highlights                         ($ in thousands, except for per share data)Three Months Ended April 30,    Nine Months Ended April 30,    2025   2024  Change   2025   2024  ChangeNet Sales$2,894,816  $2,801,113  3.3%  $7,055,707  $7,509,241  (6.0)%Gross Profit$443,119  $421,852  5.0%  $969,758  $1,050,631  (7.7)%Gross Profit Margin % 15.3%  15.1% +20 bps   13.7%  14.0% (30) bpsNet Income Attributable t...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 31, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: June 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

THOR Industries Announces Participation in Upcoming Investor Conferenc...

THOR Industries Announces Participation in Upcoming Investor Conference ELKHART, Ind., May 29, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that the management team will be participating in an upcoming investor conference. THOR management will be hosting a fireside chat along with one-on-one meetings with analysts and institutional investors at the following event: Baird Global Consumer, Technology & Services Conference on June 5, 2025, in New York, NY. Management in attendance will include: Todd Woelfer, Senior Vice President & COO of THOR Industries, andSe...

Bluelinx Holdings Inc: 1 director

A director at Bluelinx Holdings Inc bought 3,050 shares at 68.890USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

 PRESS RELEASE

THOR Industries Announces Date for its Fiscal 2025 Third Quarter Earni...

THOR Industries Announces Date for its Fiscal 2025 Third Quarter Earnings Release ELKHART, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that the date for its fiscal 2025 third quarter earnings release will be on Wednesday, June 4, 2025, before the market opens. Upon the release of THOR's fiscal 2025 third quarter earnings, the Company will concurrently publish a copy of the earnings release, a comprehensive question and answer document and a slide presentation on the Company's website. To view the quarterly earnings documents, please go to . A...

 PRESS RELEASE

OPKO Health to Participate in Two Upcoming Investor Conferences

OPKO Health to Participate in Two Upcoming Investor Conferences MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in two investor conferences over the coming weeks. H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York City. Management will hold one-on-one meetings with investors and will participate in a fireside discussion at 9:00 a.m. Eastern time. Jefferies Global Healthcare Conference, June 3-5 at the Marriott Marquis in New York City. Management will hold one-on-one meet...

 PRESS RELEASE

THOR Industries, Inc. Welcomes Seth Woolf to Executive Team

THOR Industries, Inc. Welcomes Seth Woolf to Executive Team ELKHART, Ind., May 13, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO), the world’s largest manufacturer of recreational vehicles, is pleased to announce that Seth Woolf has joined the company as Head of Corporate Development & Investor Relations. Mr. Woolf joins THOR in a strategic leadership role focused on supporting the development of long-term corporate initiatives and strengthening the Company’s capital markets communications. “Seth brings a unique and valuable combination of industry insight and financial exper...

 PRESS RELEASE

OPKO Health Reports First Quarter 2025 Business Highlights and Financi...

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2025. Highlights from the first quarter of 2025 and recent weeks include the following: Signed definitive agreement with Labcorp to sell oncology and related clinical testing assets of BioReference Health (BioReference). The transaction includes the sale of BioReference’s laboratory te...

 PRESS RELEASE

OPKO Health to Report First Quarter 2025 Financial Results on April 30...

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Wednesday, April 30, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on April 30th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to p...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch